communityacquir
pneumonia
cap
third
caus
death
worldwid
marco
et
al
ruuskanen
et
al
although
agent
commonli
detect
adult
streptococcu
pneumonia
marco
et
al
new
high
sensit
techniqu
allow
detect
mani
respiratori
virus
associ
adult
cap
johnston
et
al
marco
et
al
mostli
influenza
viru
flu
johnston
et
al
luchsing
et
al
respiratori
syncyti
viru
rsv
luchsing
et
al
parainfluenza
viru
piv
henrickson
human
metapneumoviru
hmpv
luchsing
et
al
rhinoviru
rv
luchsing
et
al
human
coronaviru
hcov
johnston
et
al
luchsing
et
al
berri
et
al
also
detect
pathogen
role
controversi
human
bocaviru
hbov
rare
detect
adult
berri
et
al
appropri
manag
cap
requir
identif
potenti
etiolog
agent
antigen
detect
immunofluoresc
assay
ifa
routin
use
detect
respiratori
virus
children
good
perform
loeffelholz
chonmaitre
howev
highli
sensit
techniqu
must
use
adult
due
low
viral
shed
casianocolon
et
al
fox
loeffelholz
chonmaitre
real
time
revers
transcriptionpolymeras
chain
reaction
rtrtpcr
nucleic
acid
amplif
method
use
diagnost
enhanc
viral
detect
high
sensit
new
methodolog
luminex
system
increas
diagnost
capac
allow
detect
mani
virus
time
fox
krunic
et
al
loeffelholz
chonmaitre
furthermor
commerci
kit
avail
xtag
rvp
assay
method
display
sensit
ifavir
cultur
sensit
specif
rtpcr
gadsbi
et
al
howev
recent
studi
choudhari
et
al
sensit
xtag
rvp
pediatr
popul
wherea
sensit
inhous
convent
rtpcr
real
time
rtpcr
respect
adult
xtag
rvp
scantili
studi
studi
patient
divers
respiratori
ill
includ
et
al
costa
et
al
therefor
perform
adult
cap
unknown
sinc
xtag
rvp
perform
may
differ
differ
popul
cap
public
health
problem
necessari
establish
perform
pneumonia
optim
diagnosi
therefor
medic
manag
patient
type
sampl
affect
diagnost
techniqu
perform
varieti
differ
respiratori
sampl
method
nasal
oro
nasopharyng
wash
swab
aspir
appli
respiratori
virus
detect
discrep
result
ieven
lieberman
et
al
loeffelholz
chonmaitre
kim
et
al
irv
et
al
huijsken
et
al
jeong
et
al
compar
studi
diagnost
method
done
common
respiratori
virus
lieberman
et
al
even
fewer
done
adult
jeong
et
al
perform
sampl
vari
accord
detect
method
appli
sensit
npa
np
vari
children
accord
viru
detect
ieven
huijsken
et
al
thu
clinic
diagnost
influenc
pannel
respiratori
viru
search
sampl
method
use
aim
studi
compar
respiratori
virus
detect
luminex
xtag
rvp
rtrtpcr
ifa
adult
present
cap
secret
obtain
two
nasopharyng
secret
sampl
swab
aspir
crosssect
studi
conduct
patient
year
age
present
cap
admit
three
public
hospit
cl
universidad
de
chile
dr
lucio
c
ordova
san
jo
e
one
privat
health
center
cl
santa
mar
santiago
chile
june
decemb
studi
approv
univers
health
institut
ethic
committe
subject
gave
written
inform
consent
enrol
cap
defin
presenc
acut
respiratori
symptom
less
week
chest
xray
show
new
pulmonari
infiltr
exclus
criteria
includ
immunocompromis
condit
ie
human
immunodefici
viru
infect
activ
treatment
cancer
organ
transplant
immunosuppress
therapi
hospit
within
day
preced
enrol
inform
age
gender
prior
antibiot
treatment
comorbid
diabet
mellitu
chronic
obstruct
pulmonari
diseas
asthma
cardiac
failur
liver
damag
renal
neurolog
diseas
record
patient
standard
file
chest
radiograph
pattern
describ
independ
radiologist
alveolar
interstiti
mix
infiltr
patient
sever
assess
first
hr
enrol
pneumonia
sever
index
psi
describ
fine
et
al
evalu
gender
age
neoplas
cardiac
respiratori
renal
ill
clinic
paramet
respiratori
rate
puls
etc
xray
laboratori
paramet
hematocrit
partial
pressur
oxygen
pleural
effus
etc
accord
fine
score
patient
classifi
mild
score
sever
cap
score
total
respiratori
specimen
use
studi
nasopharyng
aspir
npa
nasopharyng
swab
np
npa
np
obtain
patient
time
sampl
obtain
day
admiss
use
plastic
tube
npa
flexibl
swab
copan
brescia
itali
nurs
physic
therapist
staff
sampl
immedi
transport
ice
univers
transport
media
utm
brescia
itali
laboratori
process
direct
simultan
ifa
nucleic
acid
extract
aliquot
also
store
indirect
immunofluoresc
assay
ifa
smear
prepar
triplic
ifa
perform
rsv
adenoviru
adv
flu
ab
piv
use
monoclon
antibodi
chemicon
temecula
ca
hmpv
use
antibodi
millipor
temecula
ca
conjug
sigmaaldrich
st
loui
mo
describ
elsewher
luchsing
et
al
nucleic
acid
extract
total
nucleic
acid
extract
ml
respiratori
sampl
sacac
biotechnolog
kit
como
itali
accord
manufactur
instruct
multiplex
real
time
rtpcr
real
time
revers
transcript
polymeras
chain
reaction
amplifi
fragment
differ
gene
adv
hbov
rsv
hmpv
piv
rv
hcov
use
arvi
screen
realtm
kit
ab
influenza
virus
influenza
b
realtm
kit
accord
manufactur
instruct
sacac
biotechnolog
except
volum
proport
te
buffer
cdna
revers
transcript
step
perform
appli
biosystem
austria
thermal
cycler
multiplex
rtpcr
rotor
gene
australia
real
time
thermal
cycler
luminex
xtag
w
rvp
detect
rsv
hmpv
rventeroviru
rvev
piv
type
one
four
adv
hbov
flu
flu
b
hcov
perform
luminex
xtag
respiratori
viral
panel
fast
kit
luminex
corp
toronto
canada
luminex
accord
instruct
brief
techniqu
nucleic
acid
amplifi
use
pcr
label
short
sequenc
tag
primer
dna
specif
viral
target
lengthen
target
specif
primer
extens
tspe
colorcod
bead
antitag
sequenc
specif
join
tag
primer
identifi
laser
comparison
group
test
use
ttest
quantit
variabl
exact
fisher
test
categor
variabl
sensit
specif
predict
kappa
valu
xtag
rvp
calcul
use
rtrtpcr
result
refer
assay
routin
method
receiv
oper
characterist
curv
roc
area
curv
auc
viral
detect
xtag
rvp
ifa
calcul
level
signific
set
p
analys
perform
use
graphpad
prism
san
diego
ca
stata
version
softwar
colleg
station
tx
hospit
adult
cap
enrol
includ
analys
test
rtrtpcr
xtag
rvp
fast
median
age
year
rang
male
ratio
virus
detect
case
patient
without
viral
detect
similar
age
median
year
rang
year
gender
male
vs
p
day
evolut
median
vs
rang
day
p
sever
cap
sever
p
comorbid
significantli
frequent
group
without
viral
detect
vs
p
hypertens
frequent
comorbid
group
patient
studi
virus
detect
rtrtpcr
xtag
rvp
fast
p
rtrtpcr
patient
test
posit
rv
flu
ab
six
rsv
three
adv
three
piv
three
hmpv
one
hcov
six
case
two
virus
detect
rv
flu
adv
flu
adv
hbov
luminex
patient
test
posit
rv
flu
ab
five
rsv
four
piv
four
hmpv
two
adv
two
hcov
one
hbov
nine
case
two
virus
detect
rv
adv
hbov
hcov
four
flu
b
p
number
respiratori
specimen
test
npa
np
patient
type
sampl
among
virus
detect
rtrtpcr
luminex
p
fulli
concord
observ
specimen
ident
posit
result
neg
result
assay
overal
rate
concord
good
kappa
coeffici
fourteen
sampl
posit
rtrtpcr
xtag
rvp
fast
viral
detect
discord
specif
viru
posit
rate
rtrtpcr
xtag
rvp
statist
differ
concord
rang
fair
hcov
perfect
rsv
tabl
ifa
detect
virus
patient
significantli
lower
rtrtpcr
luminex
p
two
virus
sampl
detect
four
case
rtrtpcr
seven
xtag
rvp
fast
total
viral
detect
respect
tabl
rhinoviru
common
agent
detect
method
perform
xtag
rvp
fast
use
rtrtpcr
assay
routin
method
agent
overal
detect
provid
tabl
ii
although
detect
rate
viru
rtrtpcr
luminex
similar
npa
test
p
discord
case
tabl
si
compris
virus
addit
detect
xtag
rvp
fast
nine
rtrtpcr
extra
detect
xtag
rvp
eleven
rvev
two
hcov
two
piv
one
adv
hbov
hmpv
mean
fluoresc
intens
mif
extra
detect
rtrtpcr
five
rv
one
viru
piv
flu
b
hcov
adv
cycl
threshold
ct
tabl
si
ifa
detect
two
flu
virus
one
rsv
npa
two
virus
detect
one
patient
rtrtpcr
two
luminex
increas
viral
detect
respect
p
tabl
rhinoviru
agent
commonli
detect
tabl
perform
xtag
rvp
fast
show
tabl
ii
although
detect
rate
viru
rtrtpcr
luminex
similar
np
p
virus
addit
posit
rtrtpcr
eight
rv
one
adv
one
piv
xtag
rvp
fast
eleven
rvev
two
flu
one
hmpv
one
tabl
sii
total
patient
discord
viral
detect
posit
case
rtrtpcr
neg
luminex
ct
opposit
situat
mif
tabl
sii
ifa
detect
flu
rsv
one
case
one
np
test
rate
detect
overal
posit
rate
npa
higher
np
method
rtrtpcr
p
xtag
rvp
p
respect
overal
viral
detect
npa
np
rtrtpcr
p
luminex
detect
virus
npa
np
p
patient
pair
npa
np
test
rtrtpcr
posit
rate
npa
np
p
k
result
concord
neg
posit
case
flu
flu
b
rv
rsv
one
one
adv
hcov
hmpv
hbov
two
case
virus
identifi
type
sampl
differ
flu
npa
rv
np
one
case
npa
rv
np
anoth
adult
virus
detect
np
six
patientsal
rvand
npa
includ
rv
one
flu
three
adv
one
coinfect
rv
anoth
piv
rv
two
case
flu
rv
hbov
also
detect
npa
npa
np
patient
test
xtag
rvp
fast
six
posit
sampl
six
npa
three
np
thu
posit
rate
npa
np
p
kappa
coeffici
match
viral
detect
two
rvev
two
hmpv
one
flu
one
hbov
rvev
one
flu
one
case
rvev
hbov
detect
addit
npa
one
rvev
one
hcov
one
piv
detect
np
adult
cap
case
herein
studi
overal
respiratori
virus
detect
rate
new
luminex
xtag
rvp
fast
rtrtpcr
techniqu
similar
vs
p
agre
previou
public
children
adult
global
respiratori
infect
consequ
includ
routin
laboratori
test
due
high
frequenc
viral
detect
patient
confirm
relev
role
virus
adult
pneumonia
henrickson
johnston
et
al
marco
et
al
ruuskanen
et
al
luchsing
et
al
contrari
poorer
perform
ifa
assay
p
confirm
ineffect
respiratori
virus
detect
adult
liolio
et
al
legoff
et
al
lee
et
al
fox
ieven
ginocchio
et
al
gadsbi
et
al
although
lower
cost
easi
implement
explain
wide
use
addit
ifa
oper
depend
detect
five
virus
wherea
xtag
rvp
rtrtpcr
abil
test
much
virus
run
mani
sampl
simultan
thu
although
luminex
expens
techniqu
worth
applic
consid
shorten
patient
treatment
hospit
stay
mahoni
et
al
dunda
et
al
good
perform
xtag
rvp
regard
rtrtpcr
observ
npa
np
sensit
rang
describ
popul
pabbaraju
et
al
gadsbi
et
al
methodolog
pabbaraju
et
al
jokela
et
al
popowitch
et
al
howev
virus
detect
rtrtpcr
luminex
spite
nucleic
acid
extract
test
techniqu
uniqu
extract
method
sacac
kit
appli
assum
differ
extract
method
test
influenc
result
krunic
et
al
complet
rule
verheyen
et
al
discrep
result
might
also
explain
better
primer
target
rtpcr
rtrtpcr
perform
immedi
collect
extract
use
xtag
rvp
frozen
order
enough
number
sampl
reduc
cost
thu
sampl
low
viral
load
accord
high
ct
could
lost
rna
thaw
result
neg
luminex
howev
fact
explain
discrep
two
case
show
ct
detect
rtrtpcr
ct
nine
rv
detect
method
xtag
rvp
specif
lower
publish
popul
methodolog
pabbaraju
et
al
gadsbi
et
al
baladallasat
et
al
jokela
et
al
sinc
xtag
rvp
distinguish
rv
ev
differ
could
due
extra
case
ev
detect
luminex
gadsbi
et
al
extra
detect
virus
might
fals
posit
least
two
four
case
flu
confirm
convent
rtpcr
sampl
previous
obtain
hospit
clinic
practic
relev
establish
best
type
respiratori
sampl
viral
detect
author
recommend
np
npa
easier
obtain
better
viral
detect
loeffelholz
chonmaitre
experi
viral
detect
significantli
higher
npa
np
techniqu
less
viru
detect
np
npa
furthermor
viral
detect
either
method
np
compar
npa
even
though
sampl
could
complementari
combin
would
increas
detect
rate
would
justifi
given
addit
case
np
rhinoviru
recov
upper
respiratori
tract
whose
pathogenesi
cap
debat
luminex
xtag
rvp
appropri
assay
nasopharyng
aspir
optim
type
respiratori
sampl
detect
respiratori
viru
adult
cap
thank
cristian
moreno
dina
silva
support
technic
help
appli
methodolog
work
also
thank
ms
patricia
cabrera
hospit
cl
u
chile
nurs
physic
therapist
staff
hospit
dr
l
c
ordova
complejo
hospitalario
san
jo
e
cl
santa
mar
sampl
studi
approv
univers
health
institut
ethic
committe
